DWTX — Dogwood Therapeutics Share News
0.000.00%
Last trade - 00:00Virios Therapeutics nosedives on pricing stock offering
Brief: Virios Therapeutics Announces Pricing Of Public Offering
Virios Therapeutics continues plunge on planned stock offering
Brief: Virios Therapeutics Announces Proposed Public Offering
U.S. STOCKS ON THE MOVE-Rumble Inc, Virios Therapeutics, KnowBe4
U.S. STOCKS ON THE MOVE-Take-Two, Virios Therapeutics, Netflix
Virios plunges after fibromyalgia drug fails mid-stage study
Brief: Virios Therapeutics Announces Results From Mid-Stage Study Of Imc-1 In Fibromyalgia
Brief: Virios Therapeutics Announces Dosing Of First Patient In Imc-2 Long-Covid Treatment Trial
Brief: Virios Therapeutics reports Q2 results
Brief: Virios Therapeutics Inc Files For Mixed Shelf Of Upto $150 Mln
Brief: Virios Therapeutics Announces Q4, FY 2021 Financial Results
Brief: Virios Therapeutics Announces Research Collaboration For Treating Long Covid
Brief: Virios Therapeutics - Has Withdrawn Application For IND Focused On Treatment Of Irritable Bowel Syndrome By Its Lead Compound, IMC-1
Brief: Virios Therapeutics Achieves Over 50% Enrollment Milestone In Its Phase 2B Clinical Trial For Fibromyalgia
Brief: Virios Therapeutics Announces Third Quarter 2021 Financial Results
U.S. STOCKS ON THE MOVE-Ford, Genius Sports, GameStop
U.S. STOCKS ON THE MOVE-Virios, McAfee, Perrigo
Virios Therapeutics rises on new U.S. patent for antiviral combination therapy